Recently L.E.M laboratory management participated in the Israeli cancer association annual conference, taking place in Kfar Hamacabiya, Ramat-Gan. We presented Prosigna- a genomic test for breast cancer patients, identifying 10 year risk of recurrence and subtype, which we perform in L.E.M lab. As always, we were impressed by the devotion of researchers, medical staff and the association members, dedicated to fighting this disease.